Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04185337 · ClinicalTrials.gov registry record · Early Phase 1

Ultrasound-Guided Photoacoustic Imaging for the Detection of Metastases in Inguinal Lymph Nodes

A Early Phase 1 study, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
Early Phase 1
Development phase
23
Enrollment target

NCT04185337: Completed Early Phase 1 study, sponsored by M.D. Anderson Cancer Center.

NCT04185337 is a Early Phase 1 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04185337, a Early Phase 1 study, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
Early Phase 1
Development phase
23 participants
Enrollment target

Study Summary

This early phase I trial studies how well ultrasound-guided photoacoustic imaging works in telling the difference between healthy and cancerous inguinal (groin) lymph nodes and how well it can detect certain features of lymph nodes, including size and shape in patients with cancer. Ultrasound-guided photoacoustic is a non-invasive imaging method that can detect and display characteristics of lymph nodes based on the level of oxygen in the cells. This imaging method may provide more accurate tumor staging and prevent unnecessary surgical interventions.

Interventions

  • PROCEDURE Photoacoustic Imaging
  • PROCEDURE Ultrasound
  • PROCEDURE Lymph Node Biopsy
  • PROCEDURE Fine-Needle Aspiration
  • DEVICE Multispectral optoacoustic tomography (MSOT) acuity instrument

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2021-01-26
Est. Completion 2025-02-25
Phase Early Phase 1

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT04185337

The ClinicalTrials.gov registry entry for NCT04185337 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Photoacoustic Imaging is the first listed.

NCT04185337 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04185337 about?

NCT04185337 is a clinical study titled "Ultrasound-Guided Photoacoustic Imaging for the Detection of Metastases in Inguinal Lymph Nodes". This early phase I trial studies how well ultrasound-guided photoacoustic imaging works in telling the difference between healthy and cancerous inguinal (groin) lymph nodes and how well it can detect certain features of lymph nodes, including size and shape in patients with cancer. Ultrasound-guided...

What is the current status of trial NCT04185337?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 23 participants. The study started on 2021-01-26. Estimated completion is 2025-02-25.

What interventions are being tested in trial NCT04185337?

The interventions under investigation include: Photoacoustic Imaging (PROCEDURE), Ultrasound (PROCEDURE), Lymph Node Biopsy (PROCEDURE), Fine-Needle Aspiration (PROCEDURE), Multispectral optoacoustic tomography (MSOT) acuity instrument (DEVICE).

Who is sponsoring clinical trial NCT04185337?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.